To transform the lives of people affected by rare diseases and devastating conditions by continuously innovating and creating meaningful value in all that we do.
Our research and development is fueled by a relentless sense of urgency and an steadfast commitment to helping more rare disease patients and their families around the world.
Learn how we are addressing some of today’s most pressing rare disease challenges by investigating in new targets, modalities and technologies, with more opportunities for innovation than ever before.
Patient Support • June 25, 2024
Patient Support • November 08, 2023
Getting to Know Mary Kunjappu, an Alexion R&D Leading Voice
Clinical Trials • November 07, 2023
Understanding & Overcoming the Challenges in Rare Disease Clinical Trials
Patient Support • April 18, 2024
Getting to know Sophia Zilber, Associate Director, Statistical Programming
Research and Development • June 08, 2024
Getting to know Seng Cheng, an Alexion R&D Leading Voice
Patient Support • April 16, 2024
Diagnostics and artificial intelligence (AI) systems are transforming research and development (R&D) in the healthcare industry.
Clinical Trials • November 01, 2023
Alexion’s leadership in rare disease is driven by the many individuals whose expertise, creativity and tenacity fuel our commitment to advancing innovative science.
Health Equity • February 06, 2024
Collectively, more than 400 million people around the world are living with a rare disease, defined as conditions that affect a small number of people compared to the general population.
Veeva ID: GL/ALL/0071